Stay updated with breaking news from For Settlement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lyon and Cambridge , March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics , a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today...
Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketPHAXIAM remains listed on Eu...
Investegate announcements from PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
Effectiveness of Voluntary Delisting of IDEX Biometrics ADSs from Nasdaq Capital Market